Question · Q2 2026
Cameron McDonald inquired about the potential impact of GLP-1 use on other parts of Amcor's business, particularly ultra-high processed foods, snacks, and confectionery, and whether it creates a structural headwind for the 60% of the business exposed to nutrition.
Answer
CEO Peter Konieczny acknowledged the positive health trend driven by GLP-1 and Amcor's participation in the healthcare sector. He believes that while it may cause a shift from unhealthy to healthier categories within snacking, Amcor's broad portfolio makes it robust to this trend, not a structural headwind. He noted that customers are innovating, and Amcor is well-positioned to support them through its innovation capabilities and diverse category exposure.
Ask follow-up questions
Fintool can predict
AMCR's earnings beat/miss a week before the call